Agendia and AstraZeneca partner with Netherlands Cancer Institute to develop targeted therapies for colorectal cancer

Agendia N.V.

the Netherlands / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

AstraZeneca plc

U.K. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced